Japanese
English
Access
Contact
Site Map
What are iPS cells?
For patients and their families
For patients
For researchers and companies
For researchers
Make a Gift
RSS
Others
CiRA Reporter Vol.33 is available now
Research
T-Cell Responses in the Elderly Rise Slowly and Contract Quickly ~Learning About Individual and Age Differences in Immune Response From COVID-19 Vaccinations~
Modeling amyotrophic lateral sclerosis (ALS) in pigs -Developing a new experimental platform to test ALS gene and cell therapies-
Reproducing skeletal muscle pathology of myotonic dystrophy using patient-derived iPS cells and establishing a new system to quantitatively evaluate drug efficacy
The CiRA buildings will be closed from December 28th to January 3rd
Thyas Enters into Joint Research Agreement and Exclusive License for Data and Patents of Clinical Manufacturing of iPSC-Derived CAR-NK Cells
Genetic modifications boosting CAR signaling improve the therapeutic efficacy of iPSC-derived CAR-T cells against solid tumors
Phase 1 clinical trial of bosutinib for amyotrophic lateral sclerosis (ALS); iDReAM study
